E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events

NCT00345839 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3883

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism
Chronic Kidney Disease

Interventions

DRUG: Cinacalcet
DRUG: Placebo

Sponsor

Amgen